Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Knowledge Sourcing Intelligence | PRODUCT CODE: 1958847

Cover Image

PUBLISHER: Knowledge Sourcing Intelligence | PRODUCT CODE: 1958847

Artificial Intelligence (AI) In Medical Imaging Market - Strategic Insights and Forecasts (2026-2031)

PUBLISHED:
PAGES: 144 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 3950
PDF (Multiple User License)
USD 4550
PDF (Enterprise License)
USD 6950

Add to Cart

The AI in Medical Imaging market is forecast to grow at a CAGR of 34.4%, reaching USD 19.3 billion in 2031 from USD 4.4 billion in 2026.

The AI in medical imaging market is positioned as a core component of digital healthcare transformation. It integrates artificial intelligence with diagnostic imaging workflows to improve accuracy, speed, and clinical decision-making. Macro drivers include rising global imaging volumes, shortages of skilled radiologists, and increasing demand for early and precise disease detection. Healthcare systems are under pressure to improve efficiency while managing growing patient loads. AI-enabled imaging solutions address these needs by supporting automated image analysis and prioritization of critical cases. These structural trends place the market on a strong long-term growth path.

Market Drivers

The increasing prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions is a major driver of market growth. These diseases rely heavily on imaging-based diagnosis and continuous monitoring. Hospitals and diagnostic centers are adopting AI tools to reduce interpretation time and minimize human error. The expansion of digital health infrastructure and electronic medical records also supports integration of AI imaging platforms into routine workflows. Government initiatives promoting healthcare digitization and innovation further encourage adoption. Advances in computing power and cloud-based systems enable scalable deployment of AI solutions across large hospital networks and imaging centers.

Market Restraints

High implementation and maintenance costs remain a key barrier, particularly for small and mid-sized healthcare facilities. AI systems require advanced hardware, software integration, and skilled personnel for operation and validation. Data privacy and cybersecurity concerns create regulatory and operational challenges. Medical imaging data is highly sensitive and must comply with strict data protection requirements. Limited availability of large, high-quality annotated datasets can affect model performance and clinical acceptance. Regulatory approval processes for AI-based diagnostic tools are complex and time consuming, which can delay commercialization and slow market entry.

Technology and Segment Insights

By technology, the market is segmented into machine learning, deep learning, and computer vision-based solutions. Deep learning holds a significant share due to its superior performance in image recognition and pattern detection. Machine learning supports workflow optimization and predictive analytics within imaging systems.

By imaging modality, key segments include X-ray, computed tomography, magnetic resonance imaging, ultrasound, and nuclear imaging. Computed tomography and magnetic resonance imaging account for major adoption because of their extensive use in oncology and neurology diagnostics. X-ray imaging continues to see strong uptake due to its high procedure volume and suitability for automation.

By application, the market includes oncology, cardiology, neurology, orthopedics, and other clinical areas. Oncology represents a leading segment as AI supports tumor detection, staging, and treatment response monitoring. End users include hospitals, diagnostic imaging centers, and research institutions. Hospitals dominate demand due to large imaging workloads and higher investment capacity.

Competitive and Strategic Outlook

Competition in the AI in medical imaging market is driven by continuous innovation in algorithms and clinical validation. Companies focus on building regulatory-compliant solutions with proven diagnostic accuracy. Strategic partnerships between technology providers and healthcare organizations support product testing and real-world deployment. Market participants emphasize interoperability with existing imaging equipment and hospital information systems. Expansion into emerging markets and customization for specific disease areas remain important growth strategies.

The AI in medical imaging market is expected to experience rapid expansion through 2031, supported by rising diagnostic needs and healthcare digitalization. Despite challenges related to cost and regulation, technological progress and clinical adoption will sustain momentum. The market will play a critical role in shaping future diagnostic practices and improving patient outcomes.

Key Benefits of this Report

  • Insightful Analysis: Gain detailed market insights across regions, customer segments, policies, socio-economic factors, consumer preferences, and industry verticals.
  • Competitive Landscape: Understand strategic moves by key players to identify optimal market entry approaches.
  • Market Drivers and Future Trends: Assess major growth forces and emerging developments shaping the market.
  • Actionable Recommendations: Support strategic decisions to unlock new revenue streams.
  • Caters to a Wide Audience: Suitable for startups, research institutions, consultants, SMEs, and large enterprises.

What Businesses Use Our Reports For

Industry and market insights, opportunity assessment, product demand forecasting, market entry strategy, geographical expansion, capital investment decisions, regulatory analysis, new product development, and competitive intelligence.

Report Coverage

  • Historical data from 2021 to 2024, Base Year 2025, Forecast Years 2026-2031
  • Growth opportunities, challenges, supply chain outlook, regulatory framework, and trend analysis
  • Competitive positioning, strategies, and market share evaluation
  • Revenue growth and forecast assessment across segments and regions
  • Company profiling including strategies, products, financials, and key developments
Product Code: KSI061615675

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits for the Stakeholders

2. Research Methodology

  • 2.1. Research Design
  • 2.2. Research Process
  • 2.3. Data Validation

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. Artificial Intelligence (AI) in Medical Imaging Market By Offering (2022-2030)

  • 5.1. Introduction
  • 5.2. Software
  • 5.3. Services

6. Artificial Intelligence (AI) in Medical Imaging Market By Technology (2022-2030)

  • 6.1. Introduction
  • 6.2. Machine Learning
  • 6.3. Deep Learning
  • 6.4. Computer Vision

7. Artificial Intelligence (AI) in Medical Imaging Market By Application (2022-2030)

  • 7.1. Introduction
  • 7.2. Oncology
  • 7.3. Neurology
  • 7.4. Cardiology
  • 7.5. Pulmonary
  • 7.6. Orthopedics
  • 7.7. Others

8. Artificial Intelligence (AI) in Medical Imaging Market By End-User (2022-2030)

  • 8.1. Introduction
  • 8.2. Hospitals & Clinics
  • 8.3. Diagnostics Image Centers
  • 8.4. Research Institutes
  • 8.5. Others

9. Artificial Intelligence (AI) in Medical Imaging Market By Geography (2022-2030)

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. USA
    • 9.2.2. Canada
    • 9.2.3. Mexico
  • 9.3. South America
    • 9.3.1. Brazil
    • 9.3.2. Argentina
    • 9.3.3. Others
  • 9.4. Europe
    • 9.4.1. Germany
    • 9.4.2. United Kingdom
    • 9.4.3. France
    • 9.4.4. Spain
    • 9.4.5. Italy
    • 9.4.6. Others
  • 9.5. Middle East and Africa
    • 9.5.1. Saudi Arabia
    • 9.5.2. UAE
    • 9.5.3. Others
  • 9.6. Asia Pacific
    • 9.6.1. China
    • 9.6.2. Japan
    • 9.6.3. India
    • 9.6.4. South Korea
    • 9.6.5. Indonesia
    • 9.6.6. Others

10. Competitive Environment and Analysis

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. Company Profiles

  • 11.1. General Electric Company
  • 11.2. Koninklijke Philips N.V.
  • 11.3. Siemens Healthineers AG
  • 11.4. Canon Medical Systems Corporation
  • 11.5. Hologic, Inc.
  • 11.6. Agfa-Gevaert Group
  • 11.7. Aidoc Medical, Inc.
  • 11.8. Nanox Imaging Ltd.
  • 11.9. Fujifilm Holdings Corporation
  • 11.10. Samsung Medison Co., Ltd.
  • 11.11. Sectra AB
  • 11.12. Arterys, Inc.
  • 11.13. Lunit Inc.
  • 11.14. Qure.ai Technologies Pvt. Ltd.
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!